Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.92 USD | -1.85% | -4.06% | -48.31% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.31% | 632M | |
+38.31% | 705B | |
+32.37% | 583B | |
-3.58% | 364B | |
+20.23% | 332B | |
+5.16% | 291B | |
+17.11% | 238B | |
-3.72% | 210B | |
+10.47% | 209B | |
+8.60% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Eyepoint Pharmaceuticals Insider Sold Shares Worth $990,000, According to a Recent SEC Filing